Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Releasing the lockdown in the UK Covid-19 epidemic: a stochastic model

View ORCID ProfileAnthony Lander
doi: https://doi.org/10.1101/2020.04.28.20083329
Anthony Lander
1Birmingham Women’s and Children’s Hospital, Steelhouse Lane Birmingham UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony Lander
  • For correspondence: t.lander@nhs.net
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In a classic epidemic, the infected population has an early exponential phase, before slowing and fading to its peak. Mitigating interventions may change the exponent during the rising phase and a plateau can replace a peak. With interventions comes the risk that relaxation causes a second-wave. In the UK Covid-19 epidemic, infections cannot be counted, but their influence is seen in the curve of the mortality data. This work simulated social distancing and the lockdown in the UK Covid-19 epidemic to explore strategies for relaxation.

Methods Cumulative mortality data was transposed 20 days earlier to identify three doubling periods separated by the 17th March—social distancing, and 23rd March—lockdown. A set of stochastic processes simulated viral transmission between interacting individuals using Covid-19 incubation and illness durations. Social distancing and restrictions on interactions were imposed and later relaxed.

Principal Findings Daily mortality data, consistent with that seen in the UK Covid-19 epidemic to 24th April 2020 was simulated. This output predicts that under a lockdown maintained till early July 2020, UK deaths will exceed 31,000, but leave a large susceptible population and a requirement for vaccination or quarantine. An earlier staged relaxation carries a risk of a second-wave. The model allows exploration of strategies for lifting the lockdown.

Interpretation Social distancing and the lockdown have had an impressive impact on the UK Covid-19 epidemic and saved lives, caution is now needed in planning its relaxation.

Funding Unfunded research.

Evidence before this study The classical Susceptible, Infected, Recovered, (SIR) epidemiological model with additional compartments and sophistications have been widely used to make forecasts in the Covid-19 pandemic but are not easily accessible.

Added value of this study This study adds reassurance that the interventions of social distancing introduced on the 17th March and the lockdown of the 23rd March 2020 have reduced mortality. The risks of a second-wave on their relaxation are real and illustrated graphically.

Implications of all the available evidence Together with other models, credence is given to the risks of a second-wave in the UK Covid-19 epidemic on the relaxation of restrictions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Unfunded

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is referenced

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted May 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Releasing the lockdown in the UK Covid-19 epidemic: a stochastic model
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Releasing the lockdown in the UK Covid-19 epidemic: a stochastic model
Anthony Lander
medRxiv 2020.04.28.20083329; doi: https://doi.org/10.1101/2020.04.28.20083329
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Releasing the lockdown in the UK Covid-19 epidemic: a stochastic model
Anthony Lander
medRxiv 2020.04.28.20083329; doi: https://doi.org/10.1101/2020.04.28.20083329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (411)
  • Dentistry and Oral Medicine (68)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4835)
  • Forensic Medicine (3)
  • Gastroenterology (179)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (190)
  • Health Informatics (624)
  • Health Policy (318)
  • Health Systems and Quality Improvement (202)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5306)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (683)
  • Nursing (42)
  • Nutrition (113)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (204)
  • Oncology (439)
  • Ophthalmology (139)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (128)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (775)
  • Public and Global Health (1806)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)